Literature DB >> 18192867

Stem cell marker prominin-1/AC133 is expressed in duct cells of the adult human pancreas.

Jessy Lardon1, Denis Corbeil, Wieland B Huttner, Zhidong Ling, Luc Bouwens.   

Abstract

OBJECTIVES: Many efforts are spent in identifying stem cells in adult pancreas because these could provide a source of beta cells for cell-based therapy of type 1 diabetes. Prominin-1, particularly its specific glycosylation-dependent AC133 epitope, is expressed on stem/progenitor cells of various human tissues and can be used to isolate them. We, therefore, examined its expression in adult human pancreas.
METHODS: To detect prominin-1 protein, monoclonal antibody CD133/1 (AC133 clone), which recognizes the AC133 epitope, and the alphahE2 antiserum, which is directed against the human prominin-1 polypeptide, were used. Prominin-1 RNA expression was analyzed by real-time polymerase chain reaction.
RESULTS: We report that all duct-lining cells of the pancreas express prominin-1. Most notably, the cells that react with the alphahE2 antiserum also react with the AC133 antibody. After isolation and culture of human exocrine cells, we found a relative increase in prominin-1 expression both at protein and RNA expression level, which can be explained by an enrichment of cells with ductal phenotype in these cultures.
CONCLUSIONS: Our data show that pancreatic duct cells express prominin-1 and surprisingly reveal that its particular AC133 epitope is not an exclusive stem and progenitor cell marker.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18192867     DOI: 10.1097/mpa.0b013e318149f2dc

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  39 in total

Review 1.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

Review 2.  The quest for tissue stem cells in the pancreas and other organs, and their application in beta-cell replacement.

Authors:  Isabelle Houbracken; Luc Bouwens
Journal:  Rev Diabet Stud       Date:  2010-08-10

3.  Prominin-2 is a novel marker of distal tubules and collecting ducts of the human and murine kidney.

Authors:  József Jászai; Lilla M Farkas; Christine A Fargeas; Peggy Janich; Michael Haase; Wieland B Huttner; Denis Corbeil
Journal:  Histochem Cell Biol       Date:  2010-03-24       Impact factor: 4.304

4.  Colony-forming cells in the adult mouse pancreas are expandable in Matrigel and form endocrine/acinar colonies in laminin hydrogel.

Authors:  Liang Jin; Tao Feng; Hung Ping Shih; Ricardo Zerda; Angela Luo; Jasper Hsu; Alborz Mahdavi; Maike Sander; David A Tirrell; Arthur D Riggs; Hsun Teresa Ku
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

5.  Assessment of CD133-positive extracellular membrane vesicles in pancreatic cancer ascites and beyond.

Authors:  Christine A Fargeas; Jana Karbanová; Denis Corbeil
Journal:  Med Mol Morphol       Date:  2019-04-05       Impact factor: 2.309

6.  Understanding human fetal pancreas development using subpopulation sorting, RNA sequencing and single-cell profiling.

Authors:  Cyrille Ramond; Belin Selcen Beydag-Tasöz; Ajuna Azad; Martijn van de Bunt; Maja Borup Kjær Petersen; Nicola L Beer; Nicolas Glaser; Claire Berthault; Anna L Gloyn; Mattias Hansson; Mark I McCarthy; Christian Honoré; Anne Grapin-Botton; Raphael Scharfmann
Journal:  Development       Date:  2018-08-15       Impact factor: 6.868

7.  Differential expression of Prominin-1 (CD133) and Prominin-2 in major cephalic exocrine glands of adult mice.

Authors:  József Jászai; Peggy Janich; Lilla M Farkas; Christine A Fargeas; Wieland B Huttner; Denis Corbeil
Journal:  Histochem Cell Biol       Date:  2007-09-14       Impact factor: 4.304

8.  Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas.

Authors:  Irene Ischenko; Oleksi Petrenko; Michael J Hayman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

Review 9.  CD133: to be or not to be, is this the real question?

Authors:  Elena Irollo; Giuseppe Pirozzi
Journal:  Am J Transl Res       Date:  2013-09-25       Impact factor: 4.060

10.  Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB.

Authors:  Chun-Yan Li; Bao-Xiu Li; Yi Liang; Rui-Qing Peng; Ya Ding; Da-Zhi Xu; Xin Zhang; Zhi-Zhong Pan; De-Sen Wan; Yi-Xin Zeng; Xiao-Feng Zhu; Xiao-Shi Zhang
Journal:  J Transl Med       Date:  2009-07-07       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.